Cargando…

The immune response as a therapeutic target in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is a complex and heterogeneous disorder considered a liver-damaging manifestation of metabolic syndrome. Its prevalence has increased in the last decades due to modern-day lifestyle factors associated with overweight and obesity, making it a relevant public...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortiz-López, Nicolás, Fuenzalida, Catalina, Dufeu, María Soledad, Pinto-León, Araceli, Escobar, Alejandro, Poniachik, Jaime, Roblero, Juan Pablo, Valenzuela-Pérez, Lucía, Beltrán, Caroll J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589255/ https://www.ncbi.nlm.nih.gov/pubmed/36300120 http://dx.doi.org/10.3389/fimmu.2022.954869

Ejemplares similares

Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease
por: Fuenzalida, Catalina, et al.
Publicado: (2021)

α-2-Macroglobulin in Saliva Is Associated with Glycemic Control in Patients with Type 2 Diabetes Mellitus
por: Aitken, Juan Pablo, et al.
Publicado: (2015)

Socioeconomic inequalities in the incidence of alcohol-related liver disease in the Latin American context
por: Roblero, Juan Pablo, et al.
Publicado: (2021)

Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools
por: Meli, Rosaria, et al.
Publicado: (2014)

Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
por: Hernandez-Rodas, Maria Catalina, et al.
Publicado: (2015)

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
por: Duan, Yamei, et al.
Publicado: (2022)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease
por: Oates, Jarren R., et al.
Publicado: (2023)

Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease
por: Liu, Xi, et al.
Publicado: (2022)

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
por: Van Herck, Mikhaïl A., et al.
Publicado: (2019)

Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease
por: Stiglund, Natalie, et al.
Publicado: (2019)

Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
por: Oates, Jarren R., et al.
Publicado: (2019)

Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
por: Martínez-Chantar, María Luz, et al.
Publicado: (2021)

Acute liver failure due to herpes simplex virus: diagnostic clues and potential role of plasmapheresis: A case report
por: Chávez, Sebastián M., et al.
Publicado: (2021)

Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
por: Paquissi, Feliciano Chanana
Publicado: (2016)

ATP Induces IL-1β Secretion in Neisseria gonorrhoeae-Infected Human Macrophages by a Mechanism Not Related to the NLRP3/ASC/Caspase-1 Axis
por: García, Killen, et al.
Publicado: (2016)

Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
por: Pan, Xiongfeng, et al.
Publicado: (2020)

The Absence of STING Ameliorates Non-Alcoholic Fatty Liver Disease and Reforms Gut Bacterial Community
por: Zhang, Qiang, et al.
Publicado: (2022)

Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns
por: Zeng, Fanhong, et al.
Publicado: (2021)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Gallego-Durán, Rocío, et al.
Publicado: (2021)

Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
por: Fan, Yadong, et al.
Publicado: (2022)

Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease
por: Zhou, Liangliang, et al.
Publicado: (2022)

SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
por: Novo, Erica, et al.
Publicado: (2022)

The association between non-alcoholic fatty liver disease and atopic dermatitis: a population-based cohort study
por: Gau, Shuo-Yan, et al.
Publicado: (2023)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease
por: Luci, Carmelo, et al.
Publicado: (2019)

Identification of the Non-Alcoholic Fatty Liver Disease Molecular Subtypes Associated With Clinical and Immunological Features via Bioinformatics Methods
por: Liu, Ziyu, et al.
Publicado: (2022)

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
por: Ouaguia, Laurissa, et al.
Publicado: (2019)

Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients
por: Urzúa, Álvaro, et al.
Publicado: (2022)

Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
por: Piñero, Federico, et al.
Publicado: (2018)

Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Yang, Kailin, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals
por: Näslund-Koch, Charlotte, et al.
Publicado: (2022)

A rapid and simple protocol for the isolation of bacteriophages from coastal organisms
por: Echeverría-Vega, Alex, et al.
Publicado: (2019)

Salmonella Modulates B Cell Biology to Evade CD8(+) T Cell-Mediated Immune Responses
por: Lopez-Medina, Marcela, et al.
Publicado: (2014)

Optimization of In vivo Imaging Provides a First Look at Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD) Using Intravital Microscopy
por: Davis, Rachelle P., et al.
Publicado: (2020)

Increased Frequency of Dysfunctional Siglec-7(−)CD57(+)PD-1(+) Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease
por: Sakamoto, Yuzuru, et al.
Publicado: (2021)

Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis of real-world evidences
por: Gau, Shuo-Yan, et al.
Publicado: (2022)

NLRP3: a new therapeutic target in alcoholic liver disease
por: Brahadeeswaran, Subhashini, et al.
Publicado: (2023)

Immunosenescence Study of T Cells: A Systematic Review
por: Rodriguez, Ivon Johanna, et al.
Publicado: (2021)

Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases
por: Li, Xiaoxi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8qjjgbvc9oposvi9e4pmfaf34f